R
Rocío Martín-Santos
Researcher at University of Barcelona
Publications - 168
Citations - 7250
Rocío Martín-Santos is an academic researcher from University of Barcelona. The author has contributed to research in topics: Anxiety & Anxiety disorder. The author has an hindex of 43, co-authored 158 publications receiving 6301 citations. Previous affiliations of Rocío Martín-Santos include University of São Paulo & Pompeu Fabra University.
Papers
More filters
Journal ArticleDOI
Distinct effects of {delta}9-tetrahydrocannabinol and cannabidiol on neural activation during emotional processing.
Paolo Fusar-Poli,José Alexandre de Souza Crippa,Sagnik Bhattacharyya,Stefan Borgwardt,Paul Allen,Rocío Martín-Santos,Marc L. Seal,Simon Surguladze,Colin O'Carrol,Zerrin Atakan,Antonio Waldo Zuardi,Philip McGuire +11 more
TL;DR: Delta9-Tetrahydrocannabinol and CBD had clearly distinct effects on the neural, electrodermal, and symptomatic response to fearful faces, and the anxiogenic effects of Delta9-THC may be related to effects in other brain regions.
Journal ArticleDOI
Structural and Functional Imaging Studies in Chronic Cannabis Users: A Systematic Review of Adolescent and Adult Findings
Albert Batalla,Sagnik Bhattacharyya,Murat Yücel,Paolo Fusar-Poli,José Alexandre de Souza Crippa,José Alexandre de Souza Crippa,Santiago Nogué,Marta Torrens,Jesús Pujol,Magí Farré,Rocío Martín-Santos,Rocío Martín-Santos +11 more
TL;DR: Chronic cannabis use may alter brain structure and function in adult and adolescent population and functional neuroimaging studies suggest different patterns of resting global and brain activity during the performance of several cognitive tasks both in adolescents and adults may indicate compensatory effects in response to chronic cannabis exposure.
Journal ArticleDOI
Interferon-Induced Depression in Chronic Hepatitis C: A Systematic Review and Meta-Analysis
M. Udina,P. Castellví,Jose Moreno-España,Ricard Navinés,Manuel Valdés,Xavier Forns,Klaus Langohr,Ricard Solà,Eduard Vieta,Rocío Martín-Santos +9 more
TL;DR: One in 4 chronic hepatitis C patients who start interferon and ribavirin treatment will develop an induced major depressive episode, and Clinicians should attempt a full evaluation of patients before starting antiviral treatment in order to identify those at risk of developinginterferon-induced depression.
Journal ArticleDOI
Modulation of mediotemporal and ventrostriatal function in humans by Delta9-tetrahydrocannabinol: a neural basis for the effects of Cannabis sativa on learning and psychosis.
Sagnik Bhattacharyya,Paolo Fusar-Poli,Stefan Borgwardt,Rocío Martín-Santos,Chiara Nosarti,C. O'Carroll,Paul Allen,Marc L. Seal,Paul C. Fletcher,José Alexandre de Souza Crippa,Vincent Giampietro,Andrea Mechelli,Zerrin Atakan,Philip McGuire +13 more
TL;DR: The modulation of mediotemporal and ventrostriatal function by Delta9-THC may underlie the effects of C. sativa on verbal learning and psychotic symptoms, respectively.
Journal ArticleDOI
Diagnosing comorbid psychiatric disorders in substance abusers: validity of the Spanish versions of the Psychiatric Research Interview for Substance and Mental Disorders and the Structured Clinical Interview for DSM-IV.
TL;DR: Using the LEAD procedure as a "gold standard," the authors conclude that the Spanish version of the PRISM seems to be a better instrument than the Spanish versions of the SCID for diagnosing major depression and borderline personality disorders in substance abusers.